Rep. Daniel S. Goldman sold Sarepta Therapeutics (SRPT)
Rep. Daniel S. Goldman (D-NY-10) · $15K–$50K · traded Apr 10, 2023
- Transaction
- Sold
- Amount
- $15K–$50K
- Owner
- Not stated
- Traded
- Apr 10, 2023
- Disclosed
- May 19, 2023
- Days to disclose
- 39
- Asset type
- Stock
- As filed
- Sarepta Therapeutics, Inc.
- Industry
- Biotechnology · Healthcare
Other trades in this filing
All of Goldman's trades →- May 19, 2023$250K–$500K
Bought N Y ST ENV FACS CORP REV 5% 05/15/26 MN
$250K–$500K · Traded Apr 26, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold SOUTH ORANGE VLG TWP N J GO 4% 01/15/27
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold HOOVER ALA GO 4% 07/01/36 JJ
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold EWING TWP N J GO 4% 11/15/25 MN
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Bought SCHENECTADY N Y GO 4% 05/01/26 MN
$100K–$250K · Traded Apr 20, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Sold NEW JERSEY (STATE OF) GO 5% 06/01/28 JD
$100K–$250K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought N Y CITY MUN WTR FIN AUTH REV 5.0000% 06/15/31 JD
$250K–$500K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought COLONIE N Y GO 4% 03/08/24 MS
$250K–$500K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$500K–$1M
Sold N J ENV INFRASTRUCTURE TR REV 4% 09/01/27-CA MS
$500K–$1M · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought TELSTRA GROUP LTD SPONSORED ADR CMN (TLGPY)
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought SOFTBANK CORP. ADR CMN (SOBKY)
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought DORM AUTH OF THE STATE OF NY REV 5.0000% 10/01/26 AO
$250K–$500K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$15K–$50K
$15K–$50K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$50K–$100K
$50K–$100K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Computershare Limited CMSQY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Qantas Airways Limited QABSY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Sold (partial) MIAMI-DADE CNTY FLA 5% 07-01- 2025 BEO
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought West Japan Railway Company WJRYY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Central Japan Railway Company CJPRY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Bought LOCKPORT CITY N Y SCH DIST GO 5% 04/15/28 AO
$100K–$250K · Traded Apr 12, 2023 · disclosed May 19, 2023
Recent Congress trades in SRPT
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Apr 14, 2025 · disclosed May 6, 2025
- Aug 21, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Sarepta Therapeutics SRPT
$1K–$15K · Traded Jul 14, 2023 · disclosed Aug 21, 2023 · Joint
- Jul 11, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Jun 13, 2023 · disclosed Jul 11, 2023 · Joint
- Apr 20, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Sarepta Therapeutics SRPT
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 17, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Bought Sarepta Therapeutics SRPT
$15K–$50K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
Company context for SRPT
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
SRPT: third_quarter 2026 lobbying report
H.R. 9260 - LHHS Appropriations Rare Pediatric Disease Priority Review Voucher (PRV) Program Issues related to patient access to treatment National Security Commission on emerging biotechnology policy proposals Issues related to Section 232
Public: Oct 19, 2026, 4:58 PM EDTOriginal source ↗SRPT: second_quarter 2026 lobbying report
H.R. 9260 - LHHS Appropriations H.R. 1509 - Accelerating Kids Access to Care Act Patient Access Act Issues related to patient access to treatment National Security Commission on emerging biotechnology policy proposals Issues related to supply chain Issues related to Section 232
Public: Jul 20, 2026, 1:40 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.